The global induced pluripotent stem cell (iPSC) market was valued at USD 2.1 billion in 2023, growing at a CAGR of 9.6% from 2024 to 2033. The market is expected to reach USD 5.2 billion by 2033. Due to the growing need for vaccine production, higher expenditures in the industry, and an expanding application portfolio from ongoing research and development efforts, the iPSC market is expanding quickly.
Uy88
Qh88
Clarke Speaks
Tỷ Số Macao
Tin Tức Tổng Hợp Tualatinfarmersmarket
Sunwin
The Solina Khang Điền
4ringsaccessory
Rifat
Nihalsahin